Patents by Inventor Ngai Ling MA

Ngai Ling MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridone derivatives and uses thereof in the treatment of tuberculosis
    Patent number: 9546138
    Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the inhibition of mycolic acid biosynthesis through inhibition of M. tuberculosis Enoyl Acyl Carrier Protein Reductase enzyme (InhA): wherein R1, R2, R3, R4 and R5 are as defined herein.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: January 17, 2017
    Assignee: Novartis AG
    Inventors: Ravinder Reddy Kondreddi, Ngai Ling Ma, Stefan Peukert, Srinivasa P S Rao, Manjunatha Ujjini
  • PYRIDONE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF TUBERCULOSIS
    Publication number: 20150291526
    Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the inhibition of mycolic acid biosynthesis through inhibition of M. tuberculosis Enoyl Acyl Carrier Protein Reductase enzyme (InhA): wherein R1, R2, R3, R4 and R5 are as defined herein.
    Type: Application
    Filed: December 12, 2013
    Publication date: October 15, 2015
    Applicant: Novartis AG
    Inventors: Ravinder Reddy KONDREDDI, Ujjini H. MANJUNATHA, Ngai Ling MA, Stefan PEUKERT, Srinivasa PS RAO